Literature DB >> 16113469

Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.

William MacNee1.   

Abstract

An imbalance between oxidants and antioxidants is considered to play a role in the pathogenesis of chronic obstructive pulmonary disease (COPD). There is considerable evidence that an increased oxidative burden occurs in the lungs of patients with this disorder, and this may be involved in many of the pathogenic processes, such as direct injury to lung cells, mucus hypersecretion, inactivation of antiproteases, and enhancing lung inflammation through activation of redox-sensitive transcription factors. COPD is now recognized to have multiple systemic consequences, such as weight loss and skeletal muscle dysfunction. Moreover, it is appreciated that oxidative stress extends beyond the lung and may, through similar oxidative stress mechanisms as those in the lung, contribute to several of the systemic manifestations in COPD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113469     DOI: 10.1513/pats.200411-056SF

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  109 in total

1.  Dual function inhibitors of relevance to chronic obstructive pulmonary disease.

Authors:  Dengfeng Dou; Guijia He; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2010-12-10       Impact factor: 2.823

2.  Effects of structure on inhibitory activity in a series of mechanism-based inhibitors of human neutrophil elastase.

Authors:  Dengfeng Dou; Guijia He; Rongze Kuang; Qingfong Fu; Radhika Venkataraman; William C Groutas
Journal:  Bioorg Med Chem       Date:  2010-08-05       Impact factor: 3.641

3.  Regulation of airway and alveolar epithelial cell apoptosis by p53-Induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury.

Authors:  Shwetha K Shetty; Yashodhar P Bhandary; Amarnath S Marudamuthu; Daniel Abernathy; Thirunavukkarasu Velusamy; Barry Starcher; Sreerama Shetty
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

4.  Oxidative stress in patients with COPD and pulmonary hypertension.

Authors:  Pavol Joppa; Darina Petrásová; Branislav Stancák; Zuzana Dorková; Ruzena Tkácová
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 5.  [Comorbidities of COPD].

Authors:  H Watz; H Magnussen
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

6.  Ageing, smoking and oxidative stress.

Authors:  J F Donohue
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

7.  Association of Hck genetic polymorphisms with gene expression and COPD.

Authors:  Xiaozhu Zhang; Salahaddin Mahmudi-Azer; John E Connett; Nicholas R Anthonisen; Jian-Qing He; Peter D Paré; Andrew J Sandford
Journal:  Hum Genet       Date:  2006-09-26       Impact factor: 4.132

Review 8.  The stumbling block in lung repair of emphysema: elastic fiber assembly.

Authors:  Adrian Shifren; Robert P Mecham
Journal:  Proc Am Thorac Soc       Date:  2006-07

9.  Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes.

Authors:  C Chen; M Arjomandi; I B Tager; N Holland; J R Balmes
Journal:  Eur Respir J       Date:  2007-07-25       Impact factor: 16.671

Review 10.  Potential role of stem cells in management of COPD.

Authors:  Tillie L Hackett; Darryl A Knight; Don D Sin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.